Clincosm LogoSign in Get a demo

Myelodysplastic Syndromes

Showing NaN - NaN of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Tamibarotene + Azacitidine
  • Tamibarotene Matched Placebo + Azacitidine
  • Tucson, Arizona
  • +87 more
Feb 2, 2023

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Magrolimab
  • +2 more
  • Birmingham, Alabama
  • +168 more
Dec 7, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +28 more
Nov 18, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • +3 more
  • Birmingham, Alabama
  • +26 more
Sep 12, 2022

Pathogenesis of Hematologic Malignancies

Enrolling by invitation
  • Acute Leukemia
  • +3 more
  • blood draw, bone marrow procedure, or tissue biopsy
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 9, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

MDS Trial in United States (Pracinostat, Azacitidine)

Terminated
Has Results
  • Myelodysplastic Syndromes
  • Duarte, California
  • +24 more
Feb 4, 2022

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • TregGraft (Orca-T)
  • Duarte, California
  • +13 more
Oct 28, 2021

Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (CPX-351)

Completed
  • Hematologic Malignancy
  • +4 more
  • Washington, District of Columbia
  • +12 more
Jul 20, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    Acute Myeloid Leukemia, MDS Trial in United States (ALRN-6924, ALRN-6924 in combination with cytarabine)

    Completed
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • ALRN-6924
    • ALRN-6924 in combination with cytarabine
    • Denver, Colorado
    • +5 more
    Nov 18, 2019

    MDS Trial in Germany, United States (lenalidomide)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Scottsdale, Arizona
    • +31 more
    Nov 6, 2019

    MDS Trial in Worldwide (Azacitidine, Physician Choice)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Birmingham, Alabama
    • +107 more
    Oct 16, 2019

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

    Completed
    • Leukemia
    • +4 more
    • therapeutic allogeneic lymphocytes
    • +6 more
    • Denver, Colorado
    • +13 more
    Sep 13, 2019

    Cell Damage in Acute Myeloid Leukemia, Myelodysplastic

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • cytogenetic analysis
    • +3 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Nov 30, 2017

    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Portland (biological, drug, procedure, radiation)

    Terminated
    Has Results
    • Chronic Myeloproliferative Disorders
    • +6 more
    • anti-thymocyte globulin
    • +16 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Sep 25, 2017

    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Portland (biological, drug, procedure, radiation)

    Completed
    Has Results
    • Chronic Myeloproliferative Disorders
    • +6 more
    • therapeutic allogeneic lymphocytes
    • +9 more
    • Portland, Oregon
      Knight Cancer Institute at Oregon Health and Science University
    Sep 25, 2017

    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (baclofen/amitriptyline/ketamine gel, )

    Completed
    Has Results
    • Chronic Myeloproliferative Disorders
    • +9 more
    • baclofen/amitriptyline/ketamine gel
    • placebo
    • Scottsdale, Arizona
    • +164 more
    Jul 25, 2017

    Blood Samples From Patients onClinical Trial to CINV During HSCT

    Terminated
    • Breast Cancer
    • +11 more
    • immunoenzyme technique
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    May 7, 2017

    Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Portland (moxifloxacin HCl, Placebo)

    Terminated
    • Breast Cancer
    • +11 more
    • moxifloxacin hydrochloride
    • Placebo
    • Portland, Oregon
      Knight Cancer Institute at Oregon Health and Science University
    May 7, 2017

    Chronic Myeloproliferative Disorders, Fatigue, Leukemia Trial in United States (American ginseng, )

    Completed
    Has Results
    • Chronic Myeloproliferative Disorders
    • +9 more
    • American ginseng
    • placebo
    • Scottsdale, Arizona
    • +325 more
    Dec 19, 2016

    Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic Trial in France, United States

    Completed
    Has Results
    • Leukemia, Myelocytic, Acute
    • +3 more
    • Duarte, California
    • +23 more
    Feb 8, 2016

    Bone Marrow and Blood Samples From Leukemia or Other

    Completed
    • Leukemia
    • +2 more
    • cytogenetic analysis
    • fluorescence in situ hybridization
    • Mobile, Alabama
    • +279 more
    Mar 5, 2015